Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biobased Chemicals

BASF invests in China’s Bota Bio

by Melody M. Bomgardner
March 20, 2021 | A version of this story appeared in Volume 99, Issue 10

 

BASF has invested an undisclosed sum in Bota Bio, a start-up based in Hangzhou, China. Bota, launched in 2019, is developing microbes and enzymes that produce sweeteners, vitamins, and personal care and crop protection products. BASF says the technology expands market opportunities for products that can’t be made cost effectively via conventional means. It adds that Bota’s computational abilities allow quick improvement of organisms and processes.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.